bcl6 pe (Miltenyi Biotec)
Structured Review
Bcl6 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bcl6+pe/Bcl-6+Antibody%2C+anti-human%2Fmouse%2C+REAfinity/pmc13125213-123-8-12
Average 93 stars, based on 9 article reviews
Images
Related Articles
Biomarker Discovery:Article Title: Multiplexed histology analyses for the phenotypic and spatial characterization of human innate lymphoid cells Article Snippet: .. All attempts at replication were successful for the experimental findings shown in the manuscript. n/a, because we do not compare different experimental groups n/a, because we do not compare different experimental groups For MELC: DAPI (Roche), Fibronectin (rabbit IgG; Invitrogen), anti-rabbit-PE (donkey IgG, Rockland), CD127-PE (REA279; Miltenyi), COL-IV-FITC (2F11; AntibodiesOnline), ICOS-PE (REA192; Miltenyi), Ki67-FITC (MIB1; Dako), Bcl6-PE (REA373; Miltenyi), SMA-FITC (1A4; Abcam), KLRG1-PE (REA261; Miltenyi), IRF4-PE (REA201; Miltenyi), FcER1a-PE (CRA1; Miltenyi), FoxP3-PE (PCH101; Invitrogen), NKP44-PE (2.29; Miltenyi), Pax5-PE (REA140; Miltenyi), RANKL-PE (DN254 Miltenyi), Helios-PE (22F6; Biolegend), CD123-PE (AC145; Miltenyi), Eomes-PE (WD1928; BD BioScience), CD161-PE (191B8; Miltenyi), CD16-PE (REA423; Miltenyi), CD138-PE (M115; Biolegend), CD14PE (Tük4; Miltenyi), CD141-PE (BDCA-3; Miltenyi), CD19-PE (LT19; Miltenyi), CXCR3-PE (REA232; Miltenyi), c-Kit-PE (A3C6E2; Miltenyi), CD103-PE (Ber-ACT 8; Miltenyi;), CD49a-PE (TS2/7; Biolegend), VCAM-1-PE (REA269; Miltenyi), CCR4-PE(REA279; Miltenyi), CD56-PE (AF12-7H3; Miltenyi), CD11c-PE (MJ4-27G12; Miltenyi), CD69-PE (REA824; Miltenyi), CCR5-PE (J418F1; Biolegend), CD94-PE (REA113; Miltenyi), IL1R1-PE (REA744; Miltenyi), CCR6-PE (REA190; Miltenyi), GranzA-PE (REA162; Miltenyi), IgA-PE (REA995; Miltenyi), CD200R-PE (OX-108; Biolegend), CD31-PE (9G11; R&D), IgG-PE (IS11-3B2 23; Miltenyi), Langerin-PE (REA770; Miltenyi), Staining:Article Title: Splice-site mutations in POU2AF1 are associated with B-cell lymphomagenesis and therapeutic response Article Snippet: BCR activation was determined by staining the cells with IRF4-PEVio770 (Miltenyi, Spain), phospho-SYK-PE, phospho-BTK-Alexa Fluor 647, and phospho-ERK1/2-PE-Cy7 (BD Biosciences). .. GC differentiation was evaluated by staining with EZH2-FITC, BCL6-PE, CXCR4-APC and |

